Search

everythinglearnresearchcommunity

for

Search:↓

Brain-Derived Neurotrophic Factor (BDNF) slows down hair growth and promotes hair follicle regression.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

PCOS is often linked to insulin resistance and obesity, and weight loss can improve symptoms.

Most hair follicle stem cells do not protect their DNA by dividing it unevenly.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Photothermal hydrogels are promising for infection control and tissue repair, and combining them with other treatments could improve results and lower costs.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Patients with Bohring-Opitz syndrome and ASXL1 mutations need regular kidney ultrasounds to check for tumors.

Skin bacteria, specifically Staphylococcus aureus, help in wound healing and hair growth by using IL-1β signaling. Using antibiotics on skin wounds can slow down this natural healing process.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Noncoding dsRNA boosts hair growth by activating TLR3 and increasing retinoic acid.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Lymphatic vessels are essential for hair follicle growth and skin regeneration.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

New research on prostamide F2α has led to treatments for glaucoma and eyelash growth and may have more medical uses.

Surface Plasmon Resonance is a useful tool for studying protein interactions and has potential for future technological advancements.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Beard and scalp hair cells have different gene expressions, which may affect beard growth characteristics.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Long-term minoxidil use can cause pseudoacromegaly, but stopping it improves symptoms.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Researchers created a new mouse model for studying Citrullinemia Type I and similar conditions, showing symptoms and treatment responses like those in humans.

Potassium channel openers like minoxidil help hair grow by acting on hair follicles.

The document concludes that there is no agreed-upon best method for measuring drug delivery within hair follicles and more research is needed to validate current techniques.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.